CN101934026B - Chinese medicinal composition for treating cough and asthma and preparation method thereof - Google Patents
Chinese medicinal composition for treating cough and asthma and preparation method thereof Download PDFInfo
- Publication number
- CN101934026B CN101934026B CN 201010297572 CN201010297572A CN101934026B CN 101934026 B CN101934026 B CN 101934026B CN 201010297572 CN201010297572 CN 201010297572 CN 201010297572 A CN201010297572 A CN 201010297572A CN 101934026 B CN101934026 B CN 101934026B
- Authority
- CN
- China
- Prior art keywords
- cough
- asthma
- percent
- chinese medicinal
- medicinal composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010011224 Cough Diseases 0.000 title claims abstract description 90
- 208000006673 asthma Diseases 0.000 title claims abstract description 64
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 241000675108 Citrus tangerina Species 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000000341 volatile oil Substances 0.000 claims abstract description 16
- 238000001035 drying Methods 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 9
- 230000002829 reductive effect Effects 0.000 claims abstract description 9
- 239000000706 filtrate Substances 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 210000000582 semen Anatomy 0.000 claims description 43
- 239000003814 drug Substances 0.000 claims description 38
- 241000628997 Flos Species 0.000 claims description 22
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 10
- 230000006837 decompression Effects 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 239000012467 final product Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 20
- 235000011274 Benincasa cerifera Nutrition 0.000 abstract 2
- 244000036905 Benincasa cerifera Species 0.000 abstract 2
- 241000050051 Chelone glabra Species 0.000 abstract 2
- 241000218671 Ephedra Species 0.000 abstract 2
- 241001547125 Fritillaria thunbergii Species 0.000 abstract 2
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 2
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 2
- 244000248825 Peltandra virginica Species 0.000 abstract 2
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 2
- 241001522129 Pinellia Species 0.000 abstract 2
- 235000008599 Poria cocos Nutrition 0.000 abstract 2
- 244000018633 Prunus armeniaca Species 0.000 abstract 2
- 235000009827 Prunus armeniaca Nutrition 0.000 abstract 2
- 240000000377 Tussilago farfara Species 0.000 abstract 2
- 235000004869 Tussilago farfara Nutrition 0.000 abstract 2
- 239000011363 dried mixture Substances 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 46
- 208000026435 phlegm Diseases 0.000 description 46
- 230000007812 deficiency Effects 0.000 description 16
- 208000011580 syndromic disease Diseases 0.000 description 16
- 210000004072 lung Anatomy 0.000 description 15
- 210000000214 mouth Anatomy 0.000 description 9
- 206010036790 Productive cough Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 239000003172 expectorant agent Substances 0.000 description 7
- 230000003419 expectorant effect Effects 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 5
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010061245 Internal injury Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 208000024753 bloody sputum Diseases 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 241000700198 Cavia Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 241001601725 Sthenias Species 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000029523 Interstitial Lung disease Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 229940046011 buccal tablet Drugs 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000023819 chronic asthma Diseases 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 206010037833 rales Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal composition for treating cough and asthma. The Chinese medicinal composition consists of the following raw materials in percentage by mass: 5 to 6 percent of prepared ephedra, 8 to 9 percent of apricot kernel, 8 to 9 percent of red tangerine peel, 5 to 6 percent of prepared pinellia tuber, 13 to 15 percent of tuckahoe, 13 to 15 percent of Zhejiang fritillary bulb, 13 to 15 percent of baical skullcap root, 13 to 15 percent of wax gourd seed, 9 to 10 percent of common coltsfoot flower and 5 to 6 percent of liquorice root. The invention also discloses a preparation method for the Chinese medicinal composition, which comprises the following steps of: extracting volatile oil from the weighed prepared ephedra, apricot kernel and red tangerine peel by adding water, and decocting the medicinal dregs and the prepared pinellia tuber, tuckahoe, baical skullcap root, wax gourd seed, common coltsfoot flower and liquorice root twice for 1 hour every time by adding water; combining the decoctions, filtering the decoction, and concentrating the filtrate to form thick paste with reduced pressure; and then crushing the Zhejiang fritillary bulb into fine powder, mixing the fine powder and the thick paste, drying the mixture under reduced pressure, and combining the dried mixture and the extracted volatile oil to obtain the Chinese medicinal composition. The Chinese medicinal composition can radically treat empirical cough and asthma, and also has the effect of supplementing insufficiency.
Description
Technical field
The invention belongs to technical field of Chinese medicines, relate to a kind of Chinese medicine composition for the treatment of cough and asthma, the invention still further relates to the preparation method of this Chinese medicine composition.
Background technology
Cough with asthma is the cardinal symptom of pneumonopathy.The cause of disease of cough with asthma has Exogenous and internal injuries not, and pathogenesis has dividing of cold and heat and asthenia and sthenia.Cough with asthma and expectorant are closely related, the every many folder expectorant of cough with asthma, and expectorant also often causes cough with asthma, and the relieving cough and asthma Apophlegmatisant is various clinically, but arranged dividing of cold and heat and asthenia and sthenia, uses cumbersome.
Cough with asthma is divided into excess syndrome and deficiency syndrome.It is sturdy that excess syndrome is more common in body constitution, being invaded by exogenous pathogen, and cough with asthma is from the beginning of, or the patient of chronic cough and asthma acute attack.With the cough sound pitch, it is thick to pant, or rale is arranged, or double exterior syndrome is characteristics.Cough has: cold-phlegm cough, cough due to damp-phlegm, cough due to fluid-retention, phlegm heat cough, dry stool phlegm cough, bloody sputum cough, pertinacious phlegm, old productive cough are coughed etc., all divide it with the characteristics of expectoration expectorant.Asthma then is two kinds of diseases, breathes heavily with breath speech, roar with sound speech, but clinical medication difference to asthma is little, so to breathe heavily opinion.The character of asthma also has cold and heat not.
The cough with asthma deficiency syndrome are more common in the chronic patient of prolonged illness asthenia, and with sound of cough being low and weak, the feeble QI of panting is characteristics.Deficiency syndrome are divided again: the deficiency of vital energy, the deficiency of YIN, yang deficiency, deficiency of both QI and YIN.
Actually mostly be due to the diseases caused by exogenous pathogenic factor, void is then many to be caused by internal injury.Cold-phlegm, damp-phlegm, phlegm retention and so on all belong to cold and cool property, and medication is all hot product; Heat-phlegm, dry phlegm, bloody sputum belong to excess-heat more, and medication mostly is cold and cool product.So when treatment, according to the state of an illness, distinguish the specimen emergency, make every effort to prevent and treat combination.Cough illness is repeatedly outbreak easily, and many courses of disease are touching, is difficult to speed more, for rooting is controlled, and necessary symptomatic treatment in acute condition, relieving the primary symptom in a chronic case, control combination.
The Chinese medicine composition of existing treatment excess syndrome cough with asthma can not be held concurrently and be treated the deficiency syndrome cough with asthma, and this just causes and uses cumbersomely, and radical cure time of getting up is long, is difficult to speed and heals.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine composition for the treatment of cough and asthma, can effect a radical cure the cough and asthma of excess syndrome, also have the effect of tonify deficiency, and instant effect, do not recur.
Another object of the present invention provides the preparation method of the Chinese medicine composition of above-mentioned treatment cough and asthma.
The technical solution adopted in the present invention is that a kind of Chinese medicine composition for the treatment of cough and asthma is comprised of following raw material by mass percentage:
Herba Ephedrae (processed) 5%～6%, Semen Armeniacae Amarum 8%～9%, dried tangerine peel 8%～9%, Rhizoma Pinelliae Preparata 5%～6%, Poria 13%～15%, Bulbus Fritillariae Thunbergii 13%～15%, Radix Scutellariae 13%～15%, Semen Benincasae 13%～15%, Flos Farfarae 9%～10%, Radix Glycyrrhizae 5%～6%, the quality summation of above component is 100%.
Another technical scheme of the present invention is, the preparation method of the Chinese medicine composition of above-mentioned treatment cough and asthma is carried out according to the following steps:
Step 1,
According to mass percent, take by weighing respectively 5%～6% Herba Ephedrae (processed), 8%～9% Semen Armeniacae Amarum, 8%～9% dried tangerine peel, 5%～6% Rhizoma Pinelliae Preparata, 13%～15% Poria, 13%～15% Bulbus Fritillariae Thunbergii, 13%～15% Radix Scutellariae, 13%～15% Semen Benincasae, 9%～10% Flos Farfarae, 5%～6% Radix Glycyrrhizae, the quality summation of above component is 100%;
Step 2,
With step 1 claim Herba Ephedrae (processed), Semen Armeniacae Amarum and dried tangerine peel add suitable quantity of water and extract volatile oil, remaining medicinal residues and step 1 claim Rhizoma Pinelliae Preparata, Poria, Radix Scutellariae, Semen Benincasae, Flos Farfarae and Radix Glycyrrhizae together decoct with water each 1 hour 2 times; Collecting decoction filters, and filtrate decompression is condensed into thick paste, and temperature is 50 ℃-60 ℃ in the concentration process, and vacuum is 0.06 Mpa-0.07Mpa; Then step 1 is claimed Bulbus Fritillariae Thunbergii be ground into fine powder and mix with above-mentioned thick paste, drying under reduced pressure, temperature is 60 ℃-70 ℃, vacuum is 0.07 Mpa-0.08 Mpa, the volatile oil that the dry thing that makes and said extracted go out merges, and get final product.
The present invention is the Chinese medicine composition for the treatment of cough and asthma, good effect, instant effect, reasonable recipe.Herba Ephedrae (processed), Semen Armeniacae Amarum, the tangerine cold-phlegm cough with asthma that is used for; Rhizoma Pinelliae Preparata, Poria are used for the damp-phlegm cough with asthma; Bulbus Fritillariae Thunbergii, Radix Scutellariae, Semen Benincasae are used for the heat-phlegm cough with asthma; Flos Farfarae, Radix Glycyrrhizae are used for the deficiency-phlegm cough with asthma.Be mainly used in the cough with asthma of excess syndrome, but deficiency syndrome are also had the effect of tonify deficiency, the party is no matter be the cough with asthma that the cold-phlegm damp-phlegm is discussed warmly thus, or the deficiency syndrome cough with asthma all has good therapeutic effect.
The specific embodiment
The present invention is described in detail below in conjunction with the implementation example.
The present invention is the Chinese medicine composition for the treatment of cough and asthma, is comprised of following raw material by mass percentage:
Herba Ephedrae (processed) 5%～6%, Semen Armeniacae Amarum 8%～9%, dried tangerine peel 8%～9%, Rhizoma Pinelliae Preparata 5%～6%, Poria 13%～15%, Bulbus Fritillariae Thunbergii 13%～15%, Radix Scutellariae 13%～15%, Semen Benincasae 13%～15%, Flos Farfarae 9%～10%, Radix Glycyrrhizae 5%～6%, the quality summation of above component is 100%.
The present invention relates to treat the preparation method of cough and asthma Chinese medicine composition, specifically implement according to following steps:
Step 1,
According to mass percent, take by weighing respectively 5%～6% Herba Ephedrae (processed), 8%～9% Semen Armeniacae Amarum, 8%～9% dried tangerine peel, 5%～6% Rhizoma Pinelliae Preparata, 13%～15% Poria, 13%～15% Bulbus Fritillariae Thunbergii, 13%～15% Radix Scutellariae, 13%～15% Semen Benincasae, 9%～10% Flos Farfarae, 5%～6% Radix Glycyrrhizae, the quality summation of above component is 100%;
Step 2,
With step 1 claim Herba Ephedrae (processed), Semen Armeniacae Amarum and dried tangerine peel add suitable quantity of water and extract volatile oil, remaining medicinal residues and step 1 claim Rhizoma Pinelliae Preparata, Poria, Radix Scutellariae, Semen Benincasae, Flos Farfarae and Radix Glycyrrhizae together decoct with water each 1 hour 2 times; Collecting decoction filters, and filtrate decompression is condensed into thick paste, and temperature is 50 ℃-60 ℃ in the concentration process, and vacuum is 0.06 Mpa-0.07Mpa; Then step 1 is claimed Bulbus Fritillariae Thunbergii be ground into fine powder and mix with above-mentioned thick paste, drying under reduced pressure, temperature is 60 ℃-70 ℃, vacuum is 0.07 Mpa-0.08 Mpa, the volatile oil that the dry thing that makes and said extracted go out merges, and adds suitable excipient and makes other preparations such as tablet, buccal tablet, granule, capsule.
Usage and consumption: oral, each serving restraining one day 3 times with 1.5.
Points for attention: hypertension, cardiac use the careful usefulness of anemia of pregnant woman under the doctor instructs.
Effect and the function of each raw material in this medicine cures mainly:
Herba Ephedrae (processed): have lung moistening, relieving asthma, antitussive action.The multiplex card of breathing with cough of having separated in table disease.The property that the hot loose and little double hardship of this product is fallen, but the closing of external-open fur are so that lung qi a surname is smooth; In the gas of superinverse falls, with multiple lung department respectful fall normal, so kind relievining asthma for curing mainly the key medicine of breathing with cough due to the sluggishness of lung-QI, is monarch drug in the side.
Semen Armeniacae Amarum: bitter in the mouth, slightly warm in nature; Slightly poisonous.Return lung, large intestine channel.Has the sending down the abnormal ascending QI relieving cough and asthma, the effect of loosening bowel to relieve constipation.Be used for cough and asthma, the fullness in the chest abundant expectoration, blood deficiency Tianjin is withered, the dryness of the intestine constipation.Itself and Herba Ephedrae (processed) one a surname one fall, and cooperatively interact, and the depressed lung-energy dispersing cough-relieving is monarch drug altogether.
Tangerine: acrid in the mouth, hardship, warm in nature.Return lung, spleen channel.Cold expelling, dampness, promoting the circulation of QI, the effect of expectorant.Be used for the cough due to wind and cold, the itching of the throat abundant expectoration, food stagnation is got sick from drinking too much wine, and the vomiting and nausea painful abdominal mass is vexed.
Rhizoma Pinelliae Preparata: warm in nature, acrid in the mouth belongs to product on the eliminating phlegm and lowering adverse QI.Has drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, the effect of eliminating stagnation expectorant.
Bulbus Fritillariae Thunbergii: bitter in the mouth cold in nature, return lung, heart channel.Has the heat clearing away eliminating stagnation, preventing phlegm from forming and stopping coughing.Be used for wind-heat invading the lung, phlegm-fire cough, lung abscess, acute mastitis, scrofula, sore.
Semen Benincasae: lung moistening, reduce phlegm eliminating carbuncle, diuretic.Has removing heat from the lung and dissipating phlegm, the effect of promoting diuresis and pus discharge.Be used for controlling phlegm-heat cough, lung abscess, acute appendicitis, leukorrhagia, nebulousurine etc.
Flos Farfarae: the little hardship of acrid in the mouth, warm in nature.Return lung meridian.Has nourishing the lung to keep the adverse QI downward, the effect of relieving cough and resolving phlegm.Being used for new chronic cough coughs; Asthma; The chronic cough hemoptysis.
Above dried tangerine peel, Rhizoma Pinelliae Preparata, Bulbus Fritillariae Thunbergii, stir-fry Semen Benincasae, Flos Farfarae preventing phlegm from forming and stopping coughing are ministerial drug altogether.Wherein dried tangerine peel is apt to control the cold-phlegm cough with asthma, the kind damp-phlegm cough with asthma of controlling of Rhizoma Pinelliae Preparata, and Bulbus Fritillariae Thunbergii, Semen Benincasae are apt to control the heat-phlegm cough with asthma, and Flos Farfarae is controlled new and old various cough and asthma, especially is apt to control the bloody sputum cough with asthma.
Poria: sweet in the mouth, light, property is flat.GUIXIN, lung, spleen, kidney channel.Have the promoting diuresis to eliminate damp pathogen effect and be used for edema oliguria, phlegm retention vertigo and palpitation.
Radix Scutellariae: bitter in the mouth is cold in nature.Return lung, spleen, gallbladder, large intestine, small intestine meridian.Have clearing away damp-heat, pathogenic fire purging, detoxifcation, hemostasis, antiabortive, be used for the damp-warm diseases heating, cough due to lung-heat, pneumonia, spitting of blood, jaundice, damp-heat dysentery, conjunctival congestion and swelling pain, frequent fetal movement, vascular hypertension, carbuncle sore tumefacting virus.
Poria and Radix Scutellariae in the side are all adjuvant drug, and the Radix Scutellariae clearing away lung-heat is assisted a ruler in governing a country the merit of Bulbus Fritillariae Thunbergii and Semen Benincasae heat clearing and damp drying, moistening the lung and resolving phlegm; The Poria promoting diuresis to eliminate damp pathogen is assisted a ruler in governing a country the Rhizoma Pinelliae Preparata lowering the adverse-rising QI and eliminating phlegm, and one separates the cough with asthma that phlegm retention checks.
Radix Glycyrrhizae: sweet in the mouth is flat.GUIXIN, lung, spleen, stomach warp.Has expelling phlegm for arresting cough, relieving spasm to stop pain, the effect of coordinating the actions of various ingredients in a prescription.Be used for weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, gastral cavity abdomen, the anxious pain of extremity contraction, carbuncle sore tumefacting virus, emergency drug toxicity, strong.The effect of its existing expelling phlegm for arresting cough in the side, the while carries on a shoulder pole again coordinating the actions of various ingredients in a prescription, relaxes the merit of the property of medicine, for making medicine.
Cough illness has dividing of deficiency and excess, actually mostly is due to the diseases caused by exogenous pathogenic factor, and void is then many to be caused by internal injury.Excess syndrome has again dividing of cold and heat damp-phlegm, and we are exactly in this dialectical situation, reasonable formula, Herba Ephedrae (processed), Semen Armeniacae Amarum, the tangerine cold-phlegm cough with asthma that is used for; Rhizoma Pinelliae Preparata, Poria are used for the damp-phlegm cough with asthma; Bulbus Fritillariae Thunbergii, Radix Scutellariae, Semen Benincasae are used for the heat-phlegm cough with asthma; Flos Farfarae, Radix Glycyrrhizae are used for the deficiency-phlegm cough with asthma.Pharmaceutical composition of the present invention has depressed lung-energy dispersing, and the effect of relieving cough and resolving phlegm is used for the rear expectoration of flu, abundant expectoration, rough and acute/chronic bronchitis uncomfortable in chest.Be mainly used in the cough with asthma of excess syndrome, but deficiency syndrome are also had the effect of tonify deficiency, the party is no matter be the cough with asthma that the cold-phlegm damp-phlegm is discussed warmly thus, or the deficiency syndrome cough with asthma all has good therapeutic effect.
Pharmacodynamic experiment:
1. antiasthmatic effect: the Chinese medicine composition that makes by the inventive method is prepared into capsule, to the Cavia porcellus gastric infusion, can prolong the Experimental Asthma In Guinea-pigs incubation period that acetylcholine and histamine bring out by 3,6,9/kg.Illustrate that this medicine has obvious inhibitory action to the Experimental Asthma In Guinea-pigs that acetylcholine and histamine bring out.
2. preventing phlegm from forming and stopping coughing effect: the Chinese medicine composition that makes by the inventive method is prepared into capsule, press 3,6,9/kg to the mouse stomach administration, can prolong the mouse cough incubation period that strong aqua ammonia and sulfur dioxide bring out, reduce the cough number of times, the phenol red excretion amount of mice trachea is obviously increased.Illustrate that this medicine is to SO
2The cough of induced mice has obvious inhibitory action, and good phlegm-dispelling functions is arranged.
Acute toxicity test:
Select 60 of body weight 20-24g mices, male and female half and half are divided into 3 groups at random, and 20 every group, all fasting 16 h(can't help water) after, the disposable gavage of Chinese medicine composition of the present invention (being mixed with solution) given morning next day.Experiment I group is given this asthmatic medicament solution of 0.6825 g/ml, is equivalent to 20 times of people's consumptions by 20 ml/kg() gavage; Experiment II group is equivalent to 40 times of people's consumptions to this asthmatic medicament solution of 0.6825g/ml by 40 ml/kg() gavage; Experiment III group is equivalent to 80 times of people's consumptions for this asthmatic medicament solution of 0.6825 g/ml 80 ml/kg() gavage.Observe immediately the reaction of animals situation after giving tested medicine, observe every day 2 times, Continuous Observation 7 d record the mice response situation day by day.
The result to the tested medicine of animal after, tightly observed in 7 d, animal appearance, behavioral activity, the mental status, appetite (feed consumption), defecation and color, fur and the colour of skin all change without unusual, breathe no abnormality seen, nose, eye, oral cavity be all without unusual secretions, and none is dead and poison in 3 groups 60 mice 7 d.According to statistics Wrightization method, existing assurance more than 99.99% proves that the half of mice oral administration causes mortality must be greater than 80 times of the positive usual amounts of people, and the safety of prompting oral medication is large.Therefore think that this law preparation toxicity is very low, the clinical medicine dose of recommending is safe.
Case one
Xi'an Changan District Zhang, woman, 58 years old.Suffered from cough illness more than 5 years.Whenever winter, cough and asthma is serious in going out, and all must wear masks in the activity of own home courtyard.Cough is got up out of breath, abundant expectoration, the quite severity of asthma, the easily enuresis.Take this medicine after 1 week, the cough number of times reduces, and asthma is so unobvious yet, adheres to again taking for 1 week, and disease is fully recovered.
Case two
The Xi'an poplar, man, 70 years old.Suffered from cough illness 25 years, the cough with copious phlegm of smoking and too much causing at an early age, asthma, the companion coughs up white mucus expectorant, and idol has yellowish purulent sputum, cough aggravation in early morning.Once be diagnosed as bronchial asthma, bronchitis, interstitial pneumonia etc.Though through the treatment remission.But attack times increases year by year, use this medicine after, cough is clearly better, the morbidity number of times reduces, each morbidity, 1 week of taking medicine obviously takes a turn for the better.
Embodiment 1
According to mass percent, take by weighing respectively 5% Herba Ephedrae (processed), 8% Semen Armeniacae Amarum, 8% dried tangerine peel, 5% Rhizoma Pinelliae Preparata, 15% Poria, 15% Bulbus Fritillariae Thunbergii, 15% Radix Scutellariae, 15% Semen Benincasae, 9% Flos Farfarae, 5% Radix Glycyrrhizae; With claim Herba Ephedrae (processed), Semen Armeniacae Amarum and dried tangerine peel add suitable quantity of water and extract volatile oil, remaining medicinal residues with claim Rhizoma Pinelliae Preparata, Poria, Radix Scutellariae, Semen Benincasae, Flos Farfarae and Radix Glycyrrhizae together decoct with water each 1 hour 2 times; Collecting decoction filters, and filtrate decompression is condensed into thick paste, and temperature is 50 ℃-60 ℃ in the concentration process, and vacuum is 0.06 Mpa-0.07Mpa; Then step 1 is claimed Bulbus Fritillariae Thunbergii be ground into fine powder and mix with above-mentioned thick paste, drying under reduced pressure, temperature is 60 ℃-70 ℃, vacuum is 0.07 Mpa-0.08 Mpa, the volatile oil that the dry thing that makes and said extracted go out merges, and namely makes.
Embodiment 2
According to mass percent, take by weighing respectively 6% Herba Ephedrae (processed), 9% Semen Armeniacae Amarum, 9% dried tangerine peel, 6% Rhizoma Pinelliae Preparata, 15% Poria, 13% Bulbus Fritillariae Thunbergii, 13% Radix Scutellariae, 13% Semen Benincasae, 10% Flos Farfarae, 6% Radix Glycyrrhizae; With claim Herba Ephedrae (processed), Semen Armeniacae Amarum and dried tangerine peel add suitable quantity of water and extract volatile oil, remaining medicinal residues with claim Rhizoma Pinelliae Preparata, Poria, Radix Scutellariae, Semen Benincasae, Flos Farfarae and Radix Glycyrrhizae together decoct with water each 1 hour 2 times; Collecting decoction filters, and filtrate decompression is condensed into thick paste, and temperature is 50 ℃-60 ℃ in the concentration process, and vacuum is 0.06 Mpa-0.07Mpa; Then step 1 is claimed Bulbus Fritillariae Thunbergii be ground into fine powder and mix with above-mentioned thick paste, drying under reduced pressure, temperature is 60 ℃-70 ℃, vacuum is 0.07 Mpa-0.08 Mpa, the volatile oil that the dry thing that makes and said extracted go out merges, and namely makes.
Embodiment 3
According to mass percent, take by weighing respectively 6% Herba Ephedrae (processed), 9% Semen Armeniacae Amarum, 9% dried tangerine peel, 6% Rhizoma Pinelliae Preparata, 13% Poria, 14% Bulbus Fritillariae Thunbergii, 14% Radix Scutellariae, 14% Semen Benincasae, 9.5% Flos Farfarae, 5.5% Radix Glycyrrhizae; With claim Herba Ephedrae (processed), Semen Armeniacae Amarum and dried tangerine peel add suitable quantity of water and extract volatile oil, remaining medicinal residues with claim Rhizoma Pinelliae Preparata, Poria, Radix Scutellariae, Semen Benincasae, Flos Farfarae and Radix Glycyrrhizae together decoct with water each 1 hour 2 times; Collecting decoction filters, and filtrate decompression is condensed into thick paste, and temperature is 50 ℃-60 ℃ in the concentration process, and vacuum is 0.06 Mpa-0.07Mpa; Then step 1 is claimed Bulbus Fritillariae Thunbergii be ground into fine powder and mix with above-mentioned thick paste, drying under reduced pressure, temperature is 60 ℃-70 ℃, vacuum is 0.07 Mpa-0.08 Mpa, the volatile oil that the dry thing that makes and said extracted go out merges, and namely makes.
Embodiment 4
According to mass percent, take by weighing respectively 5.5% Herba Ephedrae (processed), 8.5% Semen Armeniacae Amarum, 8.5% dried tangerine peel, 5.5% Rhizoma Pinelliae Preparata, 14% Poria, 14% Bulbus Fritillariae Thunbergii, 15% Radix Scutellariae, 15% Semen Benincasae, 9% Flos Farfarae, 5% Radix Glycyrrhizae; With claim Herba Ephedrae (processed), Semen Armeniacae Amarum and dried tangerine peel add suitable quantity of water and extract volatile oil, remaining medicinal residues with claim Rhizoma Pinelliae Preparata, Poria, Radix Scutellariae, Semen Benincasae, Flos Farfarae and Radix Glycyrrhizae together decoct with water each 1 hour 2 times; Collecting decoction filters, and filtrate decompression is condensed into thick paste, and temperature is 50 ℃-60 ℃ in the concentration process, and vacuum is 0.06 Mpa-0.07Mpa; Then step 1 is claimed Bulbus Fritillariae Thunbergii be ground into fine powder and mix with above-mentioned thick paste, drying under reduced pressure, temperature is 60 ℃-70 ℃, vacuum is 0.07 Mpa-0.08 Mpa, the volatile oil that the dry thing that makes and said extracted go out merges, and namely makes.
Claims (2)
1. Chinese medicine composition for the treatment of cough and asthma is comprised of following raw material by mass percentage:
Herba Ephedrae (processed) 5%～6%, Semen Armeniacae Amarum 8%～9%, dried tangerine peel 8%～9%, Rhizoma Pinelliae Preparata 5%～6%, Poria 13%～15%, Bulbus Fritillariae Thunbergii 13%～15%, Radix Scutellariae 13%～15%, Semen Benincasae 13%～15%, Flos Farfarae 9%～10%, Radix Glycyrrhizae 5%～6%, the quality summation of above component is 100%.
2. preparation method for the treatment of the Chinese medicine composition of cough and asthma, specifically implement according to following steps:
Step 1,
According to mass percent, take by weighing respectively 5%～6% Herba Ephedrae (processed), 8%～9% Semen Armeniacae Amarum, 8%～9% dried tangerine peel, 5%～6% Rhizoma Pinelliae Preparata, 13%～15% Poria, 13%～15% Bulbus Fritillariae Thunbergii, 13%～15% Radix Scutellariae, 13%～15% Semen Benincasae, 9%～10% Flos Farfarae, 5%～6% Radix Glycyrrhizae, the quality summation of above component is 100%;
Step 2,
With step 1 claim Herba Ephedrae (processed), Semen Armeniacae Amarum and dried tangerine peel add suitable quantity of water and extract volatile oil, remaining medicinal residues and step 1 claim Rhizoma Pinelliae Preparata, Poria, Radix Scutellariae, Semen Benincasae, Flos Farfarae and Radix Glycyrrhizae together decoct with water each 1 hour 2 times; Collecting decoction filters, and filtrate decompression is condensed into thick paste, and temperature is 50 ℃-60 ℃ in the concentration process, and vacuum is 0.06 Mpa-0.07Mpa; Then step 1 is claimed Bulbus Fritillariae Thunbergii be ground into fine powder and mix with above-mentioned thick paste, drying under reduced pressure, temperature is 60 ℃-70 ℃, vacuum is 0.07 Mpa-0.08 Mpa, the volatile oil that the dry thing that makes and said extracted go out merges, and get final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010297572 CN101934026B (en) | 2010-09-30 | 2010-09-30 | Chinese medicinal composition for treating cough and asthma and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010297572 CN101934026B (en) | 2010-09-30 | 2010-09-30 | Chinese medicinal composition for treating cough and asthma and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101934026A CN101934026A (en) | 2011-01-05 |
| CN101934026B true CN101934026B (en) | 2013-02-13 |
Family
ID=43387747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201010297572 Active CN101934026B (en) | 2010-09-30 | 2010-09-30 | Chinese medicinal composition for treating cough and asthma and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101934026B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103463604A (en) * | 2013-09-23 | 2013-12-25 | 刘雅娟 | Drug for treating cough and asthma |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1846755A (en) * | 2005-04-15 | 2006-10-18 | 陕西天禄堂制药有限责任公司 | Chinese medicine for treating bronchial asthma in acute attack stage and its prepn process |
| CN101766741A (en) * | 2008-12-31 | 2010-07-07 | 周国生 | Chinese medicine composite for treating heat asthma |
-
2010
- 2010-09-30 CN CN 201010297572 patent/CN101934026B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1846755A (en) * | 2005-04-15 | 2006-10-18 | 陕西天禄堂制药有限责任公司 | Chinese medicine for treating bronchial asthma in acute attack stage and its prepn process |
| CN101766741A (en) * | 2008-12-31 | 2010-07-07 | 周国生 | Chinese medicine composite for treating heat asthma |
Non-Patent Citations (2)
| Title |
|---|
| 舒鸿.幼畜喘息性支气管炎的辨证施治.《中兽医医药杂志》.1991,(第02期),28-29. * |
| 茹十眉.急性支气管炎.《袖珍中医处方》.上海中医学院出版社,1987,(第1版),147-149. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101934026A (en) | 2011-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104873947A (en) | Medicinal composition for treating dog acute upper gastrointestinal hemorrhage and preparation method thereof | |
| CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
| CN104001045A (en) | Drug for treating dog pneumonia and preparation method thereof | |
| CN104353028A (en) | Pharmaceutical combination for treating asthma and preparation method thereof | |
| CN101934026B (en) | Chinese medicinal composition for treating cough and asthma and preparation method thereof | |
| CN104825821A (en) | Medicine for treating diabetes and preparation method thereof | |
| CN103830653A (en) | Pure traditional Chinese medicine preparation for treating infantile persistent diarrhea and preparation method thereof | |
| CN100431595C (en) | Medicinal composition for treating qi stagnation and cold stasis stomach-ache and its preparing method and use | |
| CN103860853A (en) | Traditional Chinese medicine composition for treating asthma and preparation method thereof | |
| CN102961621A (en) | Traditional Chinese medicine preparation for treating viral cardiac neurosis | |
| CN103330867B (en) | Preparation method of powder for treating senile vaginitis | |
| CN106215149A (en) | A kind of Chinese medicine composition of cure hiccup and preparation method thereof | |
| CN104547383A (en) | Traditional Chinese medicine preparation for treating liver depression food damage type postpartum food damage and preparation method thereof | |
| CN106563076B (en) | Medicine for treating stomach disease and its preparing method | |
| CN102772645B (en) | Traditional Chinese medicine for treating cold and preparation method thereof | |
| CN104906472A (en) | Traditional Chinese medicine composition for preventing and treating cough-variant asthma | |
| CN104906337B (en) | A kind of Radix Glycyrrhizae pear Bulbus Fritillariae Ussuriensis and preparation method | |
| CN104147229B (en) | A kind of compound Chinese medicinal preparation for the treatment of female climacteric syndrome kidney yin and yang deficiency type | |
| CN115869375B (en) | Traditional Chinese medicine composition for clearing heat and dispelling wind as well as preparation method and application thereof | |
| CN113713044B (en) | Traditional Chinese medicine composition for treating chronic atrophic gastritis, preparation method and application | |
| CN102716372A (en) | Traditional Chinese medicine composition for curing chronic cough, and preparation method and usage thereof | |
| CN114588228B (en) | Composition for treating type 2 diabetes | |
| CN103860852A (en) | Traditional Chinese medicine composition for treating cough and preparation method thereof | |
| CN102327526A (en) | Traditional Chinese medicine composition for lowering blood sugar | |
| CN103330861B (en) | Medicine for curing cholera and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Chinese medicinal composition for treating cough and asthma and preparation method thereof Effective date of registration: 20141216 Granted publication date: 20130213 Pledgee: Xi'an investment and financing Company limited by guarantee Pledgor: SHAANXI ACADEMY OF TRADITIONAL CHINESE MEDICINE HANTANG PHARMACEUTICAL CO.,LTD. Registration number: 2014980000050 |
|
| PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
| CP03 | Change of name, title or address |
Address after: 710300 No. 18 Caotang 4th Road, Caotang Science and Technology Industrial Base, Xi'an High-tech Zone, Shaanxi Province Patentee after: Shaanxi Hantang Pharmaceutical Co.,Ltd. Address before: 710018 No. 39 Mingguang Road, Xi'an City, Shaanxi Province Patentee before: SHAANXI ACADEMY OF TRADITIONAL CHINESE MEDICINE HANTANG PHARMACEUTICAL CO.,LTD. |
|
| CP03 | Change of name, title or address | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190626 Granted publication date: 20130213 Pledgee: Xi'an investment and financing Company limited by guarantee Pledgor: Shaanxi Hantang Pharmaceutical Co.,Ltd. Registration number: 2014980000050 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PM01 | Change of the registration of the contract for pledge of patent right |
Change date: 20190626 Registration number: 2014980000050 Pledgor after: Shaanxi Hantang Pharmaceutical Co.,Ltd. Pledgor before: SHAANXI ACADEMY OF TRADITIONAL CHINESE MEDICINE HANTANG PHARMACEUTICAL CO.,LTD. |
|
| PM01 | Change of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Chinese medicinal composition for treating cough and asthma and preparation method thereof Effective date of registration: 20190628 Granted publication date: 20130213 Pledgee: Qin Shaanxi Rural Commercial Bank branch of agricultural Limited by Share Ltd. Pledgor: Shaanxi Hantang Pharmaceutical Co.,Ltd. Registration number: 2019610000136 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210607 Granted publication date: 20130213 Pledgee: Qin Shaanxi Rural Commercial Bank branch of agricultural Limited by Share Ltd. Pledgor: Shaanxi Hantang Pharmaceutical Co.,Ltd. Registration number: 2019610000136 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to a traditional Chinese medicine composition for treating cough and asthma and a preparation method thereof Effective date of registration: 20210608 Granted publication date: 20130213 Pledgee: Qin Shaanxi Rural Commercial Bank branch of agricultural Limited by Share Ltd. Pledgor: Shaanxi Hantang Pharmaceutical Co.,Ltd. Registration number: Y2021610000135 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230607 Granted publication date: 20130213 Pledgee: Qin Shaanxi Rural Commercial Bank branch of agricultural Limited by Share Ltd. Pledgor: Shaanxi Hantang Pharmaceutical Co.,Ltd. Registration number: Y2021610000135 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A traditional Chinese medicine composition for treating cough and asthma and its preparation method Effective date of registration: 20230612 Granted publication date: 20130213 Pledgee: Qin Shaanxi Rural Commercial Bank branch of agricultural Limited by Share Ltd. Pledgor: Shaanxi Hantang Pharmaceutical Co.,Ltd. Registration number: Y2023980043784 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |